Zobrazeno 1 - 10
of 12
pro vyhledávání: '"N. Kokosadze"'
Autor:
T. Byalik, N. Kokosadze, E. Paramonova, D. Semichev, ?. Odzharova, A. Semenova, G. Tumyan, E. Osmanov
Publikováno v:
HemaSphere, Vol 6, Pp 1741-1742 (2022)
Externí odkaz:
https://doaj.org/article/b17a3767211e4398a93f79a3ba900a69
Autor:
IZ Zavodnova, NV Volkova, O P Trofimova, MYu Kichigina, Gayane Tumyan, EV Paramonova, N. Kokosadze, YuE Ryabukhina, OA Kolomeitsev, YuI Pryamikova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 59-67 (2018)
Background. Primary mediastinal (thymic) large B-cell lymphoma (PMBCL) is one of the primary extranodal tumors and originates from B-cells of thymic medulla. This disease is characterized by specific immunomorphologic and genetic features which disti
Autor:
B. Chaltsev, A. Kovrigina, E. Sokol, I. Gayduk, S. Palshina, N. Probatova, V. Vasilyev, T. Safonova, N. Kokosadze, A. Pavlovskaya
Publikováno v:
Other orphan diseases.
Background Lymphadenopathy (LA) is a frequent and challenging syndrome in rheumatic patients. It requires comprehensive clinical and expert pathological evaluation. IgG4-related disease (IgG4-RD) combines a group of fibroinflammatory conditions chara
Autor:
Y. Ribykhina, I. Subortceva, N. Kuprishina, R. Ivashenko, S. Lepkov, O. Ettinger, Igor G. Nikitin, K. Savkina, S. Borisovskay, P. Zeynalova, G. Tumian, N. Kokosadze, O. Kolomiytcev, E. Sholokhova
Publikováno v:
Hematological Oncology. 37:439-440
Publikováno v:
Poster Presentations.
Background According to 2009 Japanese nationwide survey of IgG4-related disease (IgG4-RD), orbit is the leading site of affection [1]. However diagnostic criteria and nomenclature of IgG4-RD were developed a few years later [2,3]. Objectives To evalu
Autor:
V. Vasilyev, T. Safonova, N. Kokosadze, I Gaiduk, N. Probatova, Vadim R. Gorodetskiy, A. Pavlovskaya, A. Kovrigina
Publikováno v:
Poster Presentations.
Background It is assumed that in ophthalmological clinical practice lymphoproliferative disorders in patients with affection of different orbital organs and tissues constitute 25–55% and 21% of patients have IgG4-related ophthalmic disease [1,2]. O
Autor:
O. Zaharov, S. Lepkov, G. Tumian, N. Kuprichina, I. Lazarev, T. Padgeva, O. Ettinger, V. Ivanova, N. Kokosadze, J. Ribykhina, S. Borisovskay, A. Lepkov, I. Subortceva, R. Ivashenco, Igor G. Nikitin, O. Kolomeitcev, P. Zeynalova, N. Petrenco
Publikováno v:
HemaSphere. 3:911
Autor:
I. Subortceva, P. Zeynalova, S. Lepkov, O. Zacharov, I. Lazarev, Igor G. Nikitin, G. Tumyan, N. Kokosadze, J. Ribykhina, N. Kuprishina, O. Kolomiytcev, S. Borisovskaya, O. Ettinger, R. Ivashenco, J. Kluchagina, V. Ivanova
Publikováno v:
Hematological Oncology. 37:454-454
Autor:
V. Ivanova, O. Ettinger, N. Kupryshina, A. A. Semenova, O. Urvanceva, I. Lazarev, A. Alla Kovrigina, S. Borisovskaya, Igor G. Nikitin, O. Kolomejtsev, G. Tumyan, Y. Ryabukhina, I. Subortceva, I. Komarov, Y. Kemizh, S. Lepkov, O. Malikhova, P. Zejnalova, R. Ivashhenko, N. Kokosadze
Publikováno v:
Hematological Oncology. 35:376-376
Autor:
A. Kovrigina, E. Sokol, V. Vasilyev, E. Rodionova, S. Palshina, S. Smirnova, T. Safonova, N. Kokosadze
Publikováno v:
Annals of the Rheumatic Diseases. 74:824.1-824
Background IgG4-related disease (IgG4-RD) is a distinct entity, characterized by tumefactive fibro-inflammatory lesions rich in polyclonal IgG4-positive plasma cells, storiform fibrosis, obliterative phlebitis and often elevated serum IgG4 concentrat